Study: Brand-Name Drugs’ High Copays Soak Medicare Part D Patients
A new study takes a fresh measure of generic drugs’ price advantages, revealing how much more Medicare Part D patients shelled out in copayments for two popular brand-name drugs in 2013.
The result: 10.5 times more.